ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,842.63
1.12%
Dow Jones
43,006.59
1.14%
US Dollar vs MXN
20.42094
0.07%
Brent Oil
69.585
0.46%
Bitcoin
91,580.44
1.06%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Serina Therapeutics Inc (SER)

  7. Serina Therapeutics Inc (SER) Noticias

SER

Serina Therapeutics (SER)

Serina Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:SER
FechaHoraFuenteTítuloSímboloCompañía
12/02/202515:15GlobeNewswire Inc.Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of DirectorsAMEX:SERSerina Therapeutics Inc
12/02/202515:04Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
03/02/202515:30GlobeNewswire Inc.Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsAMEX:SERSerina Therapeutics Inc
03/02/202515:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:SERSerina Therapeutics Inc
15/01/202515:05GlobeNewswire Inc.Serina Therapeutics Announces Sale of UniverXome SubsidiaryAMEX:SERSerina Therapeutics Inc
14/01/202516:25GlobeNewswire Inc.Serina Therapeutics Welcomes Karen J. Wilson to its Board of DirectorsAMEX:SERSerina Therapeutics Inc
16/12/202405:00GlobeNewswire Inc.Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024AMEX:SERSerina Therapeutics Inc
11/12/202405:05GlobeNewswire Inc.Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity SummitAMEX:SERSerina Therapeutics Inc
09/12/202415:45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:SERSerina Therapeutics Inc
02/12/202416:22GlobeNewswire Inc.Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsAMEX:SERSerina Therapeutics Inc
22/11/202415:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:SERSerina Therapeutics Inc
12/11/202416:00GlobeNewswire Inc.Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business HighlightsAMEX:SERSerina Therapeutics Inc
12/11/202415:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:SERSerina Therapeutics Inc
11/11/202416:40GlobeNewswire Inc.Serina Therapeutics Makes Grants to New Employees Under Inducement PlanAMEX:SERSerina Therapeutics Inc
06/11/202415:45Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:SERSerina Therapeutics Inc
06/11/202415:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:SERSerina Therapeutics Inc
06/11/202405:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:SERSerina Therapeutics Inc
01/11/202408:15Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsAMEX:SERSerina Therapeutics Inc
02/10/202407:30GlobeNewswire Inc.Serina Therapeutics to Present at the 14th Annual Injectables SummitAMEX:SERSerina Therapeutics Inc
04/09/202417:42GlobeNewswire Inc.Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAMEX:SERSerina Therapeutics Inc
23/08/202416:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:SERSerina Therapeutics Inc
09/08/202415:15GlobeNewswire Inc.Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business HighlightsAMEX:SERSerina Therapeutics Inc
29/07/202407:30GlobeNewswire Inc.Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics SummitAMEX:SERSerina Therapeutics Inc
18/07/202416:00GlobeNewswire Inc.Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and FormulationAMEX:SERSerina Therapeutics Inc
17/07/202416:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:SERSerina Therapeutics Inc
09/07/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:SERSerina Therapeutics Inc
14/05/202415:05GlobeNewswire Inc.Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business HighlightsAMEX:SERSerina Therapeutics Inc
17/04/202415:05GlobeNewswire Inc.Serina Therapeutics Appoints Dr. Simba Gill as Executive ChairmanAMEX:SERSerina Therapeutics Inc
26/03/202416:04GlobeNewswire Inc.Serina Therapeutics Announces Completion of Merger with AgeX TherapeuticsAMEX:SERSerina Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:SER

Su Consulta Reciente

COIN
DOGEUSD
Dogecoin
COIN
BTCUSD
Bitcoin
NASDAQ
TSLA
Tesla
CCOM
US30
US 30
COIN
ADAUSD
Cardano
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
FX
EURMXN
Euro vs MXN
USOTC
BASFY
BASF (QX)
USI
USTECH100
US Tech 100
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
NYSE
NKE
Nike
CCOM
OILBRENT
Brent Oil
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios